The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
its clear to me from the comments about kiln 3 that achieving economies of scale from increased production and reduced cost per unit is the company's main target. Once economies of scale bite, the business will be insulated from price drops and will be throwing off cash for debt reduction, capex and growth. The competing needs for cash FM mentions, can be reduced by floating BE so it raises its own investment, and I believe once BM debt is dealt with and capex is self funded, the door starts to open for dividend payments. The multiple income streams mentioned years ago are now within sight, but quite rightly the company is addressing costs, production, profitability and cash generation, to then reduce debt and maintain growth. I dont have any problems with the message in this video.
i think the MM are whitling away at their tame sellers stack, it seems to me we see a flurry of buys, then a price drop, then a biggish sale from the stack then a drift up, a handful of sales, a price drop into the close and an after hours sell from the stack some days, or more recently a sell in the opening 30 mins next day, assuming i am right, it starts to come down to the size of stack and rate of attrition.
there is a post on the bmn board which refers to mustang.
dont agree with all you guys post which is generally negative, but you collectively let yourselves down badly when you attack individuals who clearly have worked hard to make industry contacts and maximise their own research. do yourselves a favour and treat others the way you would want them to treat you.
think of must as seashell that bmn the hermit crab moves into. there is no logical reason for bmn to change its name. must share price will reflect what bmn pay for must, bmn share price will be driven by demand for the shares taking into account newsflow. must shareholders likely to receive cash, or bmn shares. i think the action will be on the parrallel JSE listing when that goes live. not advice just my opinion.
they would have to buy out bmn in its entirety in what would be a hostile T/O. Not impossible I suppose. They cant come in and buy say VRBH or the electrolite factory or a parcel of mining land without BMN agreement. Also acacia are major shareholders in must, bmn and vrfbh so its all pretty wrapped up tight.
this passage recounts how otto (garnet) emailed prince ( enerox director, witness for garnet and since left to join largo) where otto details his views that vrfbh wasnt ready for IPO but could be in months and a US raise was preferred (but would mean not via Must) and the 2 expert broker witnesses were brought in to argue the toss for both sides, it was apparent that garnet wanted control and a US IPO with bushveld out and US Vanadium in. Bushveld wanted Must in as investors and a UK main market listing. The view expressed was the view of garnet, there was a counter view from our side that the garnet view was biased and opinion not fact. BMN have repeatedly said they desire a JSE listing and have maintained Must involvement. Must are a cash shell and currently we wait for their prospectus which I believe is in turn waiting for public news on trading and strategy from BMN, as we all are.
mustang are our friends and the intention stated in court was for bmn to rto into mustang and as a result be listed on main market. garnet were the enemy who we defended against in court as they wanted mustang out of the picture so they could take enerox to the us market, taking control away from bushveld by having them sign over our shares to them as penalty for breach of the JV between us and garnet. thankfully the judge saw sense. MUST are in limbo waiting to issue a prospectus as a green energy investment vehicle, and get their shares relisted. IMO we are getting our ducks in a row to buy out MUST, and thats why we have invested time and money in all the recent RNS info keeping them involved. MUST ownership in VRFB helps us maintain control there vs garnet who are also invested, but would happily wrest control from us if they could. You cant list in parallel from AIM to JSE main list but with ftse main listing you can. this latest appointment is a bloke with heavyweight corporate history, respected in SA, and a good addition to any prospectus document or JSE application. google RTO if you want to know how it works or visit the boards of a share on lse where an RTO has happened or is happening to see the flow of RNS announcements. I dont agree there is no advantage in an RTO as cost speed and complexity all compare favourably to a direct main list application, but having MUST as an ally as a defensive measure against any threat to ownership is a factor here also. If the RTO route is off the table, it hasnt been announced, so on that basis thats how I think it will play out.